Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Commercialization
Fierce Pharma
McKesson acquires Maryland CRO for $2.25 billion
Healthcare conglomerate McKesson has dropped $2.25 billion for Precision Medicine Group's R&D and commercialization capabilities.
Donavyn Coffey
Aug 25, 2026 11:22am
Fierce Pharma
FDA backtracks on Sarepta's gene therapy Elevidys in DMD
Jul 28, 2025 6:02pm
Outlook lays off 23% of staff as it eyes FDA approval, EU debut
Dec 16, 2024 8:25am
Dicerna wants partner to sell nedosiran
Aug 10, 2021 8:00am
Epizyme CEO Bazemore passes the baton for 'next phase of growth'
Aug 9, 2021 10:44am
Leveraging Data and Real-World Evidence to Drive Product Success
May 17, 2021 9:00am